Literature DB >> 16174884

A reversible generalized movement disorder in critically ill children with cancer.

Raja B Khan1, Jeffrey E Schmidt, Robert F Tamburro.   

Abstract

INTRODUCTION: Some children treated for cancer become critically ill because of immune suppression and sepsis requiring prolonged intensive care support and assisted ventilation.
METHODS: Over a 3-year-period, we have identified six children (four with brain tumors) who developed a generalized movement disorder during a protracted intensive care unit stay. Median age was 2 years (range 1-6 years). Movement disorder developed while receiving multiple medications.
RESULTS: Sedation was achieved with midazolam and opioid infusions. Dystonic posturing of limbs, jaw movements, tongue thrusting, and intermittent eye deviations were present in all. Movements increased if the child was stimulated and an electroencephalogram performed in five children excluded seizures.
CONCLUSIONS: This movement disorder should be differentiated from seizures to prevent inappropriate treatment. Exacerbation with stimulation is a clinical clue to the correct diagnosis and an electroencephalogram can help differentiate this movement disorder from seizures.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16174884     DOI: 10.1385/ncc:3:2:146

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  12 in total

1.  Movement disorder after withdrawal of fentanyl infusion.

Authors:  J C Lane; M B Tennison; S T Lawless; R S Greenwood; A L Zaritsky
Journal:  J Pediatr       Date:  1991-10       Impact factor: 4.406

Review 2.  Complications of sedation with midazolam in the intensive care unit and a comparison with other sedative regimens.

Authors:  A Shafer
Journal:  Crit Care Med       Date:  1998-05       Impact factor: 7.598

3.  Reciprocal changes in dopamine responsiveness in the nucleus accumbens shell and core and in the dorsal caudate-putamen in rats sensitized to morphine.

Authors:  C Cadoni; G Di Chiara
Journal:  Neuroscience       Date:  1999-05       Impact factor: 3.590

4.  Fentanyl-induced dyskinesias.

Authors:  G Petzinger; S A Mayer; S Przedborski
Journal:  Mov Disord       Date:  1995-09       Impact factor: 10.338

5.  Parkinson's disease in a chemist working with 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine.

Authors:  J W Langston; P A Ballard
Journal:  N Engl J Med       Date:  1983-08-04       Impact factor: 91.245

6.  Myoclonus associated with treatment with high doses of morphine: the role of supplemental drugs.

Authors:  J M Potter; D B Reid; R J Shaw; P Hackett; P E Hickman
Journal:  BMJ       Date:  1989-07-15

7.  Symptomatic dystonias associated with structural brain lesions: report of 16 cases.

Authors:  V S Kostić; M Stojanović-Svetel; A Kacar
Journal:  Can J Neurol Sci       Date:  1996-02       Impact factor: 2.104

8.  Effect of neuroleptic drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis.

Authors:  T Zetterström; T Sharp; U Ungerstedt
Journal:  Eur J Pharmacol       Date:  1984-10-30       Impact factor: 4.432

9.  Effects of midazolam and flunitrazepam on the release of dopamine from rat striatum measured by in vivo microdialysis.

Authors:  K Takada; T Murai; T Kanayama; N Koshikawa
Journal:  Br J Anaesth       Date:  1993-02       Impact factor: 9.166

10.  Encephalopathy with parkinsonian features in children following bone marrow transplantations and high-dose amphotericin B.

Authors:  S H Mott; R J Packer; L G Vezina; S Kapur; P A Dinndorf; J A Conry; M R Pranzatelli; R R Quinones
Journal:  Ann Neurol       Date:  1995-06       Impact factor: 10.422

View more
  1 in total

Review 1.  [Neurotoxicity of general anesthetics in childhood: does anesthesia leave its mark on premature babies, newborns and infants?].

Authors:  B Sinner; K Becke; K Engelhard
Journal:  Anaesthesist       Date:  2013-02       Impact factor: 1.041

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.